ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

55 hedge funds and large institutions have $104M invested in Oncternal Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
55
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$23M
2
+$3.37M
3
+$2.77M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.75M
5
State Street
State Street
Massachusetts
+$1.17M

Top Sellers

1
-$4.29M
2
-$3.42M
3
-$1.55M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$943K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$886K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$2.31K
52
$2K
53
$2K
54
$1K
55
$1K
56
$1K
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
1 2
3